Acute Leukemias (complete) Flashcards

1
Q

Describe leukemic stem cells

A
  • Potential for crazy amounts of self renewal
  • Also differentiate into leukemic blasts cells
  • THIS IS WHERE IT ALL BEGINS!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the risk factors for acute leukemia? — Remember, however, that majority of acute leukemias occur in absence of risk factors

A

1) Previous chemo (remember DNA damage from alkylating agents or topoisomerase II inhibitors)
2) Tobacco smoke
3) Ionizing radiation
4) Benzene exposure
5) Genetic syndromes (e.g. Down syndrome, Bloom syndrome, Fanconi anemia, ataxia-telangiectasia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the common signs/symptoms exhibited by pts w/ acute leukemia at initial presentation?

A

Symptoms of anemia

1) Fatigue
2) Malaise
3) Dyspnea
4) Pallor

Symptoms of thrombocytopenia

1) Easy bruising
2) petechiae
3) Hemorrhage

Symptoms of neutropenia

1) Fever
2) Infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why are the signs and symptoms exhibited by pts w/ acute leukemia at initial presentation?

A

Decreased #s of normal peripheral blood cells — b/c of marrow infiltration by leukemic cells

Low platelets
Low RBCs
Low neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are a few basic markers that would help to assign blasts to a precursor-B, precursor-T, or myeloid lineage?

A

Pre-B: CD19, CD22

Pre-T: CD3, CD7

Mye: CD34 (myeloblasts)

Lymph: TdT (lymphoblasts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Constrast B-ALL and T-ALL in regards to pt age and sex, manner of manifestation, and prognosis

A

For T-ALL compared to B-ALL…

Age: adolescents, YA

Sex: favors males

M: presents w/ a component of T-LBL, or mediastinal mass (B-ALL no lymphoma, only leukemia)
- Have markedly elevated WBC count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 3 commonly observed cytogenetic abnormalities in B-ALL?

A

1) t(9;22)(q34;q11.2) — BCR-ABL1
2) t(11q23) — MLL
3) t(12;21)(p13;q22) — ETV6-RUNX1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the usual pt age group and prognosis associated with BCR-ABL1?

A

Philadelphia chromosome (Ph+ ALL)

A: adults, children

P: worst prognosis of any subtype of ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the usual pt age group and prognosis associated with MLL (ALL)?

A

A: neonates, young infants

P: poor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the usual pt age group and prognosis associated with ETV6-RUNX1?

A

A: children

P: very favorable!

25% of cases in childhood B-ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 5 factors affecting prognosis in ALL? Worse prognosis in parentheses.

A

1) Age (less than 1yo, more than 10yo, adults)
2) WBC count (elevated @ diagnosis)
3) Slow response to therapy or small amounts of disease after therapy
4) # of chromosomes (<46 chromosomes)
5) B vs. T lineage (T has it bad)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 2 types of findings that would allow for diagnosis of AML?

A

Increased myeloblasts accounting to >20% of nucleated cells in…

1) BM or
2) peripheral blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is an Auer rod? What is its clinical significance?

A
  • Fused azurophilic granules forming small stick-like structures in cytoplasm
  • Only seen in abnormal myeloblasts
  • Can be used in diagnosis of AML!

W/o Auer rods, you can’t differentiate btwn myeloblasts and lymphoblasts in a smear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 5 recurrent cytogenetic abnormalities for AML?

A

1) t(8;21) — RUNX1-RUNX1T1
2) inv(16) or t(16;16) — CBFC-MYH11
3) t(15;17) — PML-RARA
4) t(1;22) — RBM15-MKL1
5) 11q23 —MLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the usual pt age group and prognosis associated with RUNX1-RUNX1T1 — t(8;21)?

A

A: younger pts (20s, 30s, 40s)

P: Good prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the usual pt age group and prognosis associated with CBFC-MYH11 — inv(16) or t(16;16)?

A

A: younger pts (20s, 30s, 40s)

P: Good prognosis

Associated w/ presence of abnormal eosinophilic percursors w/ abnormal basophilic granules and eos granules (BASOS EOS!!)

17
Q

What is the usual pt age group and prognosis associated with RBM15-MKL1 — t(1;22)?

A

A: infants w/ Down syndrome

P: Good prognosis

Shows megakaryoblastic differentiation

18
Q

What is the usual pt age group and prognosis associated with MLL (AML) — 11q23?

A

A: kids and adults

P: Poor prognosis

19
Q

Explain 2 reasons why it is important to recognize at initial diagnosis that a case of AML is the AML w/ t(15;17) subtype of AML (aka: acute promyelocytic leukemia, APL)

A

1) Encodes alpha-subunit of retinoic acid — signaling required for a receptor to begin differentiation past the promyelocyte stage
- A mutation in this is a problem!
- Can be mitigated w/ retinoic acid therapy

2) Associated w/ DIC (crazy clotting and hemorrhage)

20
Q

Contrast the 2 main categories of therapy-related AML. Talk about latency, cytogenetic abnormalities, and processes to AML through an MDS stage

A

1) Alkylating agents/radiation
2) Topoisomerase Inhibitors

AA/R vs TI

L: 2-8 y vs. 1-2 y

C: complex karyotype w/ whole/partial deletions in 5 or 7 vs. rearrangement of 11q23 (MLL)

MDS?: Usually yes vs. usually no

21
Q

Compare the prognosis of the 2 main categories of therapy-related AML

A

Both BADDDDDD

22
Q

What are the 3 molecular markers currently used to predict prognosis in pts w/ AML w/ normal karyotype?

A

1) FLT3 ITD
2) NPM1
3) CEBPA

23
Q

Of the 3 molecular markers currently used to predict prognosis in pts w/ AML w/ normal karyotype, which of these trumps the other 2 as a driving prognostic factor?

A

FLT3 ITD!

You only check for NPM-1 or CERPA if you are negative for FLT3

24
Q

What are the surface markers used to diagnose AML?

A

1) CD34 (lymphoblasts)
2) CD117 - C-Kit (myeloid marker)
3) Myeloperoxidase (myeloid marker)